Hospitalizations for gastrointestinal and cardiovascular events in the CADEUS cohort of traditional or Coxib NSAID users. - Wikidata - wikimedia - TriplyDB

Hospitalizations for gastrointestinal and cardiovascular events in the CADEUS cohort of traditional or Coxib NSAID users.

Hospitalizations for gastrointestinal and cardiovascular events in the CADEUS cohort of traditional or Coxib NSAID users.

http://www.wikidata.org/entity/Q33692833

about

Adverse events associated with single dose oral analgesics for acute postoperative pain in adults - an overview of Cochrane reviews Pain management for rheumatoid arthritis and cardiovascular or renal comorbidity Nonsteroidal anti-inflammatory drugs, gastroprotection, and benefit-risk Non-steroidal anti-inflammatory drug-induced cardiovascular adverse events: a meta-analysis.Gastrointestinal toxicity among patients taking selective COX-2 inhibitors or conventional NSAIDs, alone or combined with proton pump inhibitors: a case-control study.Usage patterns of 'over-the-counter' vs. prescription-strength nonsteroidal anti-inflammatory drugs in France.Adverse drug events as a cause of hospitalization in older adults.Non-steroidal anti-inflammatory drug use in chronic pain conditions with special emphasis on the elderly and patients with relevant comorbidities: management and mitigation of risks and adverse effects.Safety and efficacy of paracetamol and NSAIDs in osteoarthritis: which drug to recommend?The past, present and perhaps future of pharmacovigilance: homage to Folke Sjoqvist.Inappropriate Use of Proton Pump Inhibitors in Elderly Patients Discharged from Acute Care Hospitals.High-dimensional versus conventional propensity scores in a comparative effectiveness study of coxibs and reduced upper gastrointestinal complications.Medications Recommended for Secondary Prevention After First Acute Coronary Syndrome: Effectiveness of Treatment Combinations in a Real-Life Setting.

P2860

Q24186666-00C30478-6875-4341-8719-B20F4027C8FF Q24235971-7AC4A87A-3362-4F78-AB63-7F7C593BB63E Q26864640-A67C87A4-D7CF-4AC7-BEFA-8400315F918E Q36233306-21F2D06C-5069-492C-87EE-06D64D3C9184 Q36332697-BA88270A-ABB6-47B9-BC06-72A796B306FE Q37731873-D37CF8D2-DC5E-4F40-9CC8-F4339255814C Q38085222-DF83E32A-C530-477B-8EDC-57D431068432 Q38243967-74F7FFB0-24D0-4512-9268-3D50894BC27F Q38541866-FB5F39A2-3BEE-47DB-955B-2C86F129AE7C Q39422837-1755A2F1-127E-40E5-8325-3B1B32DC974E Q39702517-F71FA78C-E079-4867-AA56-FE621B4E5D34 Q43701143-8DC1AF33-7D56-4E2C-9F9E-2F3194F7600A Q50217749-DE713860-0379-47EA-B5AC-92FC922EFCBD

P2860

Hospitalizations for gastrointestinal and cardiovascular events in the CADEUS cohort of traditional or Coxib NSAID users.

http://www.wikidata.org/entity/Q33692833

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Hospitalizations for gastroint ...... ditional or Coxib NSAID users.

@ast

Hospitalizations for gastroint ...... ditional or Coxib NSAID users.

@en

type

label

Hospitalizations for gastroint ...... ditional or Coxib NSAID users.

@ast

Hospitalizations for gastroint ...... ditional or Coxib NSAID users.

@en

prefLabel

Hospitalizations for gastroint ...... ditional or Coxib NSAID users.

@ast

Hospitalizations for gastroint ...... ditional or Coxib NSAID users.

@en

P1433

Q33692833-53A5444A-72B0-4076-9246-08DF159C5E95

P1476

Q33692833-2E271D5D-35F6-4A06-8046-CDD560F439C0

P2093

Q33692833-023BFA83-2D80-4E48-9964-51126F20DE95

Q33692833-11DC4EAD-9BA0-457F-86C1-AD8CDEB0749E

Q33692833-3E3ABAFC-A601-4293-9AF1-08782587F34A

Q33692833-6C8CB4B5-6BFD-4378-95CA-93E4597C48CC

Q33692833-6CCE5551-3DE1-4A11-8718-AFF994346F94

Q33692833-6F915C3F-98BE-4E1C-8397-E2FAB8EB3496

Q33692833-85D4BC10-87BA-49C4-9FA9-F2E11D2CE310

Q33692833-A4F76A64-F178-4F65-A146-7D983E7A0E45

Q33692833-A5884E5E-F8D4-4E9A-AA11-099CF937A690

Q33692833-A74DCC43-12D8-4756-ADF4-C363D41B0F50

P2860

Q33692833-01F2719B-E1BD-4EDE-9C77-424340F37424

Q33692833-07B86C6D-BFB8-4A77-8222-511DCB0D6756

Q33692833-3E30C669-A8E9-4A92-B417-839080C98616

Q33692833-483E3235-EB73-437C-A6F8-CF042BFE2507

Q33692833-50147C22-BA01-48F2-A49D-B7F236D59C92

Q33692833-56B33DB0-B2A1-4F11-BEBC-2DA36B426426

Q33692833-5810D63A-2599-4D29-B13C-B0BF4087838A

Q33692833-6D33B183-A2B0-4865-A223-1DF18E23C5D6

Q33692833-73B47012-5727-4458-A927-536554725B75

Q33692833-787295DB-AAE5-478E-86CE-8233CCAA7605

P304

Q33692833-2B317D78-B25E-4BA9-B005-90AB78169527

P31

Q33692833-139F5AD7-4A1F-4A71-9903-9F5044971B74

P356

Q33692833-E309EAFE-2DE6-48C2-A859-EA036627C316

P407

Q33692833-F77C22C0-20BD-401B-A467-43002CB551E0

P433

Q33692833-74AF179C-058A-499A-AFC6-0B5594DC8F73

P478

Q33692833-23CC53C5-0CAB-4A3F-8D5B-02AA6816D9B6

P50

Q33692833-EFF60BDD-7745-45E7-A744-E7E1085ADDC9

P577

Q33692833-7761A8E1-F1CC-41D2-8178-A062B51DE6AE

P5875

Q33692833-3BAEB2A1-F3DD-44E9-A5D9-DBF72A8104E0

P698

Q33692833-B1E747A1-A73E-4EC9-95B7-C41EB1CE913D

P921

Q33692833-AC526031-DCB4-4F1A-B205-F2CDDF11C094

P932

Q33692833-EDF64C75-111C-41EA-8AD9-78F9D8B9A6F1

P356

J.1365-2125.2009.03588.X

P1433

British Journal of Clinical Pharmacology

P1476

Hospitalizations for gastroint ...... aditional or Coxib NSAID users

@en

P2093

Annie Fourrier-Réglat

http://www.w3.org/2001/XMLSchema#string

Bernard Bégaud

http://www.w3.org/2001/XMLSchema#string

Cécile Droz-Perroteau

http://www.w3.org/2001/XMLSchema#string

David Laharie

http://www.w3.org/2001/XMLSchema#string

Estelle Guiard

http://www.w3.org/2001/XMLSchema#string

Fanny Depont

http://www.w3.org/2001/XMLSchema#string

Jacques Bénichou

http://www.w3.org/2001/XMLSchema#string

Michel Amouretti

http://www.w3.org/2001/XMLSchema#string

Nicholas Moore

http://www.w3.org/2001/XMLSchema#string

Stéphanie Lamarque

http://www.w3.org/2001/XMLSchema#string

P2860

Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials

Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis

Prescription channeling of COX-2 inhibitors and traditional nonselective nonsteroidal anti-inflammatory drugs: a population-based case-control study

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

Nonsteroidal anti-inflammatory drugs (NSAIDs), cyxlooxygenase-2 selective inhibitors (coxibs) and gastrointestinal harm: review of clinical trials and clinical practice

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.

Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group.

Wine, alcohol, platelets, and the French paradox for coronary heart disease.

P304

295-302

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2125.2009.03588.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

69

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

42108284

http://www.w3.org/2001/XMLSchema#string

P698

20233201

http://www.w3.org/2001/XMLSchema#string

P921

hospitalization

P932

2829700

http://www.w3.org/2001/XMLSchema#string